Managing the symptoms and side effects caused by pulmonary fibrosis (and its related treatments) is inevitable for all PF patients. Here are some tips for coping with them.   1. Exercise and stay active. Exercise and keeping active is extremely important in managing your pulmonary fibrosis.  Lisa...

CPFF participated at the Toronto ZoomerShow during the Oct 28-29 weekend. Hosted by Hoffman-La Roche at their FightIPF booth, CPFF volunteers were available to talked to the over 600 visitors to the booth over the weekend.  Some of the visitors were those living with IPF or some...

Attention – CPFF community in BC, Alberta, Saskatchewan and Manitoba — London Drugs  will be collecting donations for CPFF at the till from shoppers throughout the month of September to mark Pulmonary Fibrosis Month. Please encourage your family and friends to make a donation. Every bit helps!! Thank...

In this feature, the CPFF recognizes the incredible efforts of volunteers across Canada, and share regional experiences and successes to inspire and promote the wonderful work being done. This July we are recognizing volunteers in Calgary, AB for their hard work, dedication, and commitment to help Canadians...

Congratulations to the fine folks at the University of Alberta for the recognition they received for their Patient-Centred ILD Collaborative for Early Integrated Palliative Care program by the Canadian Foundation for Healthcare Improvement (CFHI). This program, along with 24 others, was selected based on its role as...

We are very proud of our CPFF BC Board Member, George Kaminsky along with other CPFF representatives in Vancouver who launched the Report Card on the BC government today with a grade of C-. The BC Report Card is based on the CPFF IPF Patient Charter, which...

A huge thank you to all of our CPFF community who participated in our needs assessment survey. We had a tremendous response with close to 600 individuals affected by PF who completed the survey. The valuable information and insights provided will be of great help to guide...

OFEV™ listed as Médicament d’Exception effective March 22nd, 2017 For treatment of idiopathic pulmonary fibrosis, in persons: • whose forced vital capacity (FVC) is 50% or more of the predicted value; and • whose carbon monoxide diffusing capacity is 30% to 79% of the predicted value corrected...

CPFF has registered for the Halifax Bluenose Marathon Charity Challenge, May 19 – 21, 2017. If you or someone you know is affected by Pulmonary Fibrosis, please plan to participate. You can put a team together or join us on your own. The CPFF information will be...